Nurix Therapeutics
在场
是其中之一......
Nurix Therapeutics 是一家在股票代码 NRIX (US) 下上市的公司。
涉及Nurix Therapeutics的并购和融资。
- Nurix Therapeutics 刚刚宣布为 175 筹款数百万美元。 (公布2024四月13号).
高管
查看带有其 31 名主要高管的组织结构图
Nurix Therapeutics 搜索最多的简介
- Arthur Sands, Chief Executive Officer and Director
- Edward Saltzman, Director
- Judith Reinsdorf, Director
高管在Nurix Therapeutics变化
- Anil Kapur已作为Director加入公司 (新闻发布的2024十月18号).
- Paula O'Connor 曾任 Executive Vice President and Head of Clinical Development, 现升职为 Chief Medical Officer (新闻发布的2024五月29号).
- Pasit Phiasivongsa 曾任 Senior Vice President, Technical Operations, 现升职为 Chief Technical Officer (新闻发布的2024五月21号).
创建提醒
跟踪 Nurix Therapeutics 的高管变动
生物技术
Nurix Therapeutics 拥有 2,337 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Aadi Bioscience 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
- OraSure Technologies has announced the acquisition of Sherlock Biosciences (公布2024十二月20号).
- SiteOne Therapeutics 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
生物技术 行业的其他推荐联系人
消息
Nurix Therapeutics 的最新新闻稿
- Nurix Therapeutics Announces Appointment of Eric Schlezinger, J.D. as Chief People Officer | Nurix Therapeutics, Inc.
- Press Releases | Nurix Therapeutics, Inc.
- Press Releases | Nurix Therapeutics, Inc.
- Press Releases | Nurix Therapeutics, Inc.
- Nurix Therapeutics Announces $40 Million Registered Direct Offering | Nurix Therapeutics, Inc.
- Press Releases | Nurix Therapeutics, Inc.
- Nurix Therapeutics Announces $55 Million Registered Direct Offering | Nurix Therapeutics, Inc.
- Nurix Therapeutics Reports Fiscal Second Quarter 2022 Financial Results and Provides a Corporate Update | Nurix Therapeutics, Inc.
- Nurix Therapeutics Announces Clearance of Investigational New Drug Application For NX-1607 Supporting Plans to Expand Enrollment to U.S. Clinical Sites | Nurix Therapeutics, Inc.
- Press Releases | Nurix Therapeutics, Inc.
- View more press releases Close
通过电子邮件
